Showing results (841-850 of 1,825) with videos related to

Sort By:
Pageof 183
Disability and Rehabilitation|April 22, 2025
The clinical effectiveness of tele-rehabilitation interventions on balance and activities of daily living in post-stroke survivors: an umbrella review of systematic reviewsMahboubeh Ghayour Najafabadi, Ardalan Shariat, Lee Ingle, et al.
Organic & Biomolecular Chemistry|January 3, 2014
Modulating glycosylation with exogenous nucleophiles: an overviewShaheen K Mulani, Wei-Cheng Hung, Arun B Ingle, et al.
Plos One|March 10, 2025
Multimodal prehabilitation in people awaiting acute inpatient cardiac surgery: Study protocol for a pilot feasibility trial (PreP-ACe)Sarah Raut, Aaron Hales, Maureen Twiddy, et al.
Women and Birth : Journal of the Australian College of Midwives|February 8, 2017
Barriers to a healthy lifestyle post gestational-diabetes: An Australian qualitative studyTehzeeb Zulfiqar, Fiona E Lithander, Cathy Banwell, et al.
Integrative and Comparative Biology|May 14, 2021
Caudal Spine Morphology and Puncture Performance of Two Coastal StingraysCaitlin S Shea-Vantine, Katherine A Galloway, Danielle N Ingle, et al.
Organic Letters|March 19, 2011
Chiral magnesium BINOL phosphate-catalyzed phosphination of imines: access to enantioenriched α-amino phosphine oxidesGajendrasingh K Ingle, Yuxue Liang, Michael G Mormino, et al.
Journal of Analytical Toxicology|September 18, 2015
Driving Under the Influence of Marijuana Versus Driving and Dying Under the Influence of Marijuana: A Comparison of Blood Concentrations of Δ9-Tetrahydrocannabinol, 11-Hydroxy-Δ9-Tetrahydrocannabinol, 11-Nor-9-Carboxy-Δ9-Tetrahydrocannabinol and Other Cannabinoids in Arrested Drivers Versus Deceased DriversNikolas P Lemos, Alexander C San Nicolas, Justin A Volk, et al.
Clinical Breast Cancer|April 6, 2006
Plasma matrix metalloproteinases 7 and 9 in patients with metastatic breast cancer treated with marimastat or placebo: Eastern Cooperative Oncology Group trial E2196Stanley Zucker, Molin Wang, Joseph A Sparano, et al.
Cancer Research|February 27, 2009
The tamoxifen metabolite, endoxifen, is a potent antiestrogen that targets estrogen receptor alpha for degradation in breast cancer cellsXianglin Wu, John R Hawse, Malayannan Subramaniam, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 19, 2009
Thresholds for therapies: highlights of the St Gallen International Expert Consensus on the primary therapy of early breast cancer 2009A Goldhirsch, J N Ingle, R D Gelber, et al.
Pageof 183